Drug Type Bispecific antibody |
Synonyms anti-HER3/anti-TRAIL bispecific antibody (Sunrock Biopharma), SRB-18 |
Target |
Action antagonists, modulators |
Mechanism HER3 antagonists(Receptor tyrosine-protein kinase erbB-3 antagonists), TRAIL modulators(Tumor necrosis factor ligand superfamily member 10 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Preclinical | Spain | - | |
Head and Neck Neoplasms | Preclinical | Spain | - | |
Stomach Cancer | Preclinical | Spain | - |